6LP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bolt Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 5.18 EUR

Market Cap: €197.5m

	Bolt Biotherapeutics Inc F:6LP	US
	Newcore Gold Ltd F:PI8	CA
R	Rua Life Sciences PLC F:AOHA	UK
B	BonTerra Resources Inc F:9BR2	CA
U	Uniti Group Inc F:8XC	US
	Tarena International Inc F:0T8B	CN
	Elementos Ltd F:9EM	AU
	Lovable Lingerie Ltd BSE:533343	IN
U	Ultra Clean Holdings Inc F:UCE	US
	Tevogen Bio Holdings Inc F:G28	US

Profitability Summary

Bolt Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-606%

Negative 3Y Average Operating Margin

-868%

Operating Margin is Increasing

-1 204% > -606%

Negative Net Margin

-611%

Negative 3Y Average Net Margin

-815%

Net Margin is Increasing

-1 133% > -611%

Negative Free Cash Flow Margin

-671%

Negative 3Y Average Free Cash Flow Margin

-826%

Free Cash Flow Margin is Increasing

-1 045% > -671%

Negative ROE

-112%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-118%

ROIC is Increasing

-115% > -94%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.